Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.76 | 26.38 |
| PEG Ratio (TTM) | -0.02 | 1.88 |
| P/S Ratio (TTM) | 0.23 | 2.08 |
| P/B Ratio (TTM) | 0.05 | 1.13 |
| P/FCF Ratio (TTM) | -6.69 | 14.93 |
| Price to 5YR AVG Earnings Ratio | N/A | 11.76 |
| Price to 5YR AVG FCF Ratio | N/A | 23.18 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.92% | 5.74% |
| ROE (TTM) | 6.83% | 8.82% |
| Net Profit Margin (TTM) | 9.65% | 6.39% |
| ROIC 5YR AVG | N/A | 8.93% |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -22.35% | 14.54% | N/A |
| Revenue | -19.86% | 22.79% | N/A |
| Net Income | -35.50% | 35.05% | N/A |
| Cash Flow | -22.11% | -38.02% | N/A |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.44 | 1.56 |
| Quick Ratio (TTM) | 0.98 | 0.94 |
| D/E Ratio (TTM) | 0.18 | 0.70 |
| Interest Coverage (TTM) | 50.58 | 14.89 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 1.97 | 3.28 |
| LTL to 5YR AVG FCF | N/A | 6.84 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.00% |